Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-07820435 |
Synonyms | |
Therapy Description |
Limited information is currently available on PF-0782043 (Apr 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-07820435 | PF07820435|PF 07820435 | Limited information is currently available on PF-07820435 (Apr 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06285097 | Phase I | PF-07820435 PF-06801591 + PF-07820435 | A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors | Active, not recruiting | USA | 2 |